123 related articles for article (PubMed ID: 17766807)
1. Efficacy of a live bovine herpesvirus type 1 marker vaccine under field conditions in three countries.
Makoschey B; Zehle HH; Bussacchini M; Valla G; Pálfi V; Földi J
Vet Rec; 2007 Sep; 161(9):295-8. PubMed ID: 17766807
[TBL] [Abstract][Full Text] [Related]
2. Aspects of bovine herpesvirus-1 infection in dairy and beef herds in the Republic of Ireland.
Cowley DJ; Clegg TA; Doherty ML; More SJ
Acta Vet Scand; 2011 Jun; 53(1):40. PubMed ID: 21699677
[TBL] [Abstract][Full Text] [Related]
3. A live bovine herpesvirus-1 marker vaccine is not shed after intramuscular vaccination.
Makoschey B; Beer M
Berl Munch Tierarztl Wochenschr; 2007; 120(11-12):480-2. PubMed ID: 18085158
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of serum antibodies to bovine herpesvirus-1 and bovine viral diarrhea virus in beef cattle in Uruguay.
Guarino H; Núñez A; Repiso MV; Gil A; Dargatz DA
Prev Vet Med; 2008 Jun; 85(1-2):34-40. PubMed ID: 18280598
[TBL] [Abstract][Full Text] [Related]
5. Persistence of bovine herpesvirus-1-specific antibodies in cattle after intranasal vaccination with a live virus vaccine.
Van der Poel WH; Kramps JA; Quak J; Brand A; Van Oirschot JT
Vet Rec; 1995 Sep; 137(14):347-8. PubMed ID: 8560685
[TBL] [Abstract][Full Text] [Related]
6. [BHV-1 eradication program in Bavaria: a marker-independent strategy].
Truyen U; Isa G; Gerbermann H; Bogner KH; Banzhaf K; Köstler M; Pauels FJ; Czerny CP; Wittkowski G
Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):197-202. PubMed ID: 12784552
[TBL] [Abstract][Full Text] [Related]
7. Bovine herpesvirus 1 (BHV1) seroprevalence in the breeding cattle population of the Veneto region: prospects for the implementation of a control programme.
Nardelli S; Marangon S; Dalla Pozza M; Ponzoni A; Viel L; Brichese M
Zentralbl Veterinarmed B; 1999 Dec; 46(10):735-40. PubMed ID: 10676153
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
[TBL] [Abstract][Full Text] [Related]
9. Effect of vaccination against bovine herpesvirus 1 with inactivated gE-negative marker vaccines on the health of dairy cattle herds.
Raaperi K; Orro T; Viltrop A
Prev Vet Med; 2015 Mar; 118(4):467-76. PubMed ID: 25662288
[TBL] [Abstract][Full Text] [Related]
10. Presence of bovine herpesvirus 1 gB-seropositive but gE-seronegative Dutch cattle with no apparent virus exposure.
Mars MH; Rijsewijk FA; Maris-Veldhuis MA; Hage JJ; van Oirschot JT
Vet Rec; 2000 Sep; 147(12):328-31. PubMed ID: 11058022
[TBL] [Abstract][Full Text] [Related]
11. A serological survey of bovine herpesvirus-1 infection in selected dairy herds in northern and central Italy.
Castrucci G; Martin WB; Frigeri F; Ferrari M; Salvatori D; Tagliati S; Cuteri V
Comp Immunol Microbiol Infect Dis; 1997 Sep; 20(4):315-7. PubMed ID: 9481516
[TBL] [Abstract][Full Text] [Related]
12. Long-term study (2005-2010) on the vaccination with BoHV-1 glycoprotein E-deleted marker vaccine in selected two dairy herds in Turkey.
Alkan F; Bilge-Dagalp S; Karapınar Z; Timurkan MO; Coskun N; Burgu I
Trop Anim Health Prod; 2018 Feb; 50(2):353-363. PubMed ID: 29071668
[TBL] [Abstract][Full Text] [Related]
13. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine.
Kaashoek MJ; Moerman A; Madić J; Rijsewijk FA; Quak J; Gielkens AL; van Oirschot JT
Vaccine; 1994 Apr; 12(5):439-44. PubMed ID: 8023552
[TBL] [Abstract][Full Text] [Related]
14. A four year longitudinal sero-epidemiological study of bovine herpesvirus type-1 (BHV-1) in adult cattle in 107 unvaccinated herds in south west England.
Woodbine KA; Medley GF; Moore SJ; Ramirez-Villaescusa AM; Mason S; Green LE
BMC Vet Res; 2009 Jan; 5():5. PubMed ID: 19183476
[TBL] [Abstract][Full Text] [Related]
15. Characterization of monoclonal antibodies directed against the bovine herpesvirus-1 glycoprotein E and use for the differentiation between vaccinated and infected animals.
Letellier C; Delangre A; De Smet A; Kerkhofs P
Vet Microbiol; 2001 Dec; 83(4):301-15. PubMed ID: 11600264
[TBL] [Abstract][Full Text] [Related]
16. [Spread of an intramuscularly administered live gE-negative BHV1 marker vaccine in 2 cattle farms].
van der Poel WH; Hage JJ
Tijdschr Diergeneeskd; 1998 Feb; 123(4):109-11. PubMed ID: 9537086
[TBL] [Abstract][Full Text] [Related]
17. An inactivated gE-negative marker vaccine and an experimental gD-subunit vaccine reduce the incidence of bovine herpesvirus 1 infections in the field.
Bosch JC; De Jong MC; Franken P; Frankena K; Hage JJ; Kaashoek MJ; Maris-Veldhuis MA; Noordhuizen JP; Van der Poel WH; Verhoeff J; Weerdmeester K; Zimmer GM; Van Oirschot JT
Vaccine; 1998; 16(2-3):265-71. PubMed ID: 9607041
[TBL] [Abstract][Full Text] [Related]
18. [Conventional and marked BHV-1 vaccines in Germany: a brief review].
Trapp S; König P; Beer M
Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):208-15. PubMed ID: 12784554
[TBL] [Abstract][Full Text] [Related]
19. Effects of hypervaccination with bovine herpesvirus type 1 gE-deleted marker vaccines on the serological response and virological status of calves challenged with wild-type virus.
Toussaint JF; Rziha HJ; Bauer B; Letellier C; Kerkhofs P
Vet Rec; 2004 Oct; 155(18):553-8. PubMed ID: 15559987
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological characteristics of bovine herpesvirus 1 infections determined by bulk milk testing of all Dutch dairy herds.
Van Wuijckhuise L; Bosch J; Franken P; Frankena K; Elbers AR
Vet Rec; 1998 Feb; 142(8):181-4. PubMed ID: 9533279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
